121 related articles for article (PubMed ID: 22340582)
1. Antitumoural hydroxyapatite nanoparticles-mediated hepatoma-targeted trans-arterial embolization gene therapy: in vitro and in vivo studies.
Li G; Ye L; Pan J; Long M; Zhao Z; Yang H; Tian J; Wen Y; Dong S; Guan J; Luo B
Liver Int; 2012 Jul; 32(6):998-1007. PubMed ID: 22340582
[TBL] [Abstract][Full Text] [Related]
2. Synergism of wt-p53 and synthetic material in local nano-TAE gene therapy of hepatoma: comparison of four systems and the possible mechanism.
Li G; Kang W; Jin M; Zhang L; Zheng J; Jia K; Ma J; Liu T; Dang X; Yan Z; Gao Z; Xu J
BMC Cancer; 2019 Nov; 19(1):1126. PubMed ID: 31747895
[TBL] [Abstract][Full Text] [Related]
3. Synergism of hydroxyapatite nanoparticles and recombinant mutant human tumour necrosis factor-alpha in chemotherapy of multidrug-resistant hepatocellular carcinoma.
Li G; Dong S; Qu J; Sun Z; Huang Z; Ye L; Liang H; Ai X; Zhang W; Chen X
Liver Int; 2010 Apr; 30(4):585-92. PubMed ID: 19780956
[TBL] [Abstract][Full Text] [Related]
4. Tumor-targeted gene therapy using Adv-AFP-HRPC/IAA prodrug system suppresses growth of hepatoma xenografted in mice.
Dai M; Liu J; Chen DE; Rao Y; Tang ZJ; Ho WZ; Dong CY
Cancer Gene Ther; 2012 Feb; 19(2):77-83. PubMed ID: 21959967
[TBL] [Abstract][Full Text] [Related]
5. Inhibition of connective tissue growth factor overexpression decreases growth of hepatocellular carcinoma cells in vitro and in vivo.
Jia XQ; Cheng HQ; Li H; Zhu Y; Li YH; Feng ZQ; Zhang JP
Chin Med J (Engl); 2011 Nov; 124(22):3794-9. PubMed ID: 22340243
[TBL] [Abstract][Full Text] [Related]
6. [Experimental research of therapeutic effect on hepatocellular carcinoma of targeting SMYD3 gene inhibition by RNA interference].
Xu JY; Chen LB; Xu JY; Yang Z; Xu RH; Wei HY
Zhonghua Wai Ke Za Zhi; 2006 Apr; 44(7):481-4. PubMed ID: 16772086
[TBL] [Abstract][Full Text] [Related]
7. Inhibition mechanism of a newly cloned candidate tumor suppressor gene JST during hepatocarcinogenesis and its abnormal expression in human hepatocellular carcinoma from Qidong liver cancer risk area, China.
Dong-Dong L; Xi-Ran Z
Hepatogastroenterology; 2004; 51(56):515-25. PubMed ID: 15086194
[TBL] [Abstract][Full Text] [Related]
8. Construction of a star-shaped copolymer as a vector for FGF receptor-mediated gene delivery in vitro and in vivo.
Li D; Ping Y; Xu F; Yu H; Pan H; Huang H; Wang Q; Tang G; Li J
Biomacromolecules; 2010 Sep; 11(9):2221-9. PubMed ID: 20704346
[TBL] [Abstract][Full Text] [Related]
9. Trans-arterial gene therapy for hepatocellular carcinoma in a rabbit model.
Gu T; Li CX; Feng Y; Wang Q; Li CH; Li CF
World J Gastroenterol; 2007 Apr; 13(14):2113-7. PubMed ID: 17465458
[TBL] [Abstract][Full Text] [Related]
10. Adenovirus vector expressing mda-7 selectively kills hepatocellular carcinoma cell line Hep3B.
Xue XB; Chen K; Wang CJ; Zheng JW; Yu Y; Peng ZH; Wu ZD
Hepatobiliary Pancreat Dis Int; 2008 Oct; 7(5):509-14. PubMed ID: 18842498
[TBL] [Abstract][Full Text] [Related]
11. A biomimetic nanovector-mediated targeted cholesterol-conjugated siRNA delivery for tumor gene therapy.
Ding Y; Wang W; Feng M; Wang Y; Zhou J; Ding X; Zhou X; Liu C; Wang R; Zhang Q
Biomaterials; 2012 Dec; 33(34):8893-905. PubMed ID: 22979990
[TBL] [Abstract][Full Text] [Related]
12. [Expression of MT1-MMP and its significance in rabbit VX2 tumor tissues after transarterial embolization with hydroxyapatite nanoparticles].
Xu T; Chen XP; Guo YX; Li D; Lu L; Huan GZ; Zhang WG
Zhonghua Wai Ke Za Zhi; 2008 Apr; 46(8):606-9. PubMed ID: 18844058
[TBL] [Abstract][Full Text] [Related]
13. HSG provides antitumor efficacy on hepatocellular carcinoma both in vitro and in vivo.
Wang W; Zhu F; Wang S; Wei J; Jia C; Zhang Y; Zhou L; Xie H; Zheng S
Oncol Rep; 2010 Jul; 24(1):183-8. PubMed ID: 20514460
[TBL] [Abstract][Full Text] [Related]
14. Augmenting the antitumor effect of TRAIL by SOCS3 with double-regulated replicating oncolytic adenovirus in hepatocellular carcinoma.
Wei RC; Cao X; Gui JH; Zhou XM; Zhong D; Yan QL; Huang WD; Qian QJ; Zhao FL; Liu XY
Hum Gene Ther; 2011 Sep; 22(9):1109-19. PubMed ID: 21361790
[TBL] [Abstract][Full Text] [Related]
15. Adenovirus vector-mediated gene transfer using degradable starch microspheres for hepatocellular carcinoma in rats.
Shiba H; Okamoto T; Futagawa Y; Misawa T; Yanaga K; Ohashi T; Eto Y
J Surg Res; 2006 Jun; 133(2):193-6. PubMed ID: 16730258
[TBL] [Abstract][Full Text] [Related]
16. [Adenovirus vector expressing MDA-7/IL-24 selectively induces growth arrests and apoptosis in human hepatocellular carcinoma cell lines independent of the state of p53 gene].
Xue XB; Zheng JW; Wang CJ; Chen K; Hu HY; Hu H; Yu Y; Wu ZD
Zhonghua Gan Zang Bing Za Zhi; 2006 Sep; 14(9):670-5. PubMed ID: 16995981
[TBL] [Abstract][Full Text] [Related]
17. [Significance of arterial infusion of SMANCS-dissolved Lipiodol in therapeutic strategies for hepatocellular carcinoma].
Jin-no K
Gan To Kagaku Ryoho; 1998 Feb; 25 Suppl 1():90-8. PubMed ID: 9512695
[TBL] [Abstract][Full Text] [Related]
18. Liver-specific gene therapy of hepatocellular carcinoma by targeting human telomerase reverse transcriptase with pegylated immuno-lipopolyplexes.
Hu Y; Shen Y; Ji B; Yin S; Ren X; Chen T; Ma Y; Zhang Z; Zhang Y
Eur J Pharm Biopharm; 2011 Aug; 78(3):320-5. PubMed ID: 21220007
[TBL] [Abstract][Full Text] [Related]
19. Biotin-directed assembly of targeted modular lipoplexes and their transfection of human hepatoma cells in vitro.
Singh A; Ariatti M; Singh M; Hawtrey A; Naidoo R
Drug Deliv; 2010 Aug; 17(6):426-33. PubMed ID: 20469969
[TBL] [Abstract][Full Text] [Related]
20. Hepatoma-targeted gene delivery using a tumor cell-specific gene regulation system combined with a human liver cell-specific bionanocapsule.
Kang JH; Oishi J; Kim JH; Ijuin M; Toita R; Jun B; Asai D; Mori T; Niidome T; Tanizawa K; Kuroda S; Katayama Y
Nanomedicine; 2010 Aug; 6(4):583-9. PubMed ID: 20138242
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
